In order to address whether the correlation between NEO1/NTN1/RGMA and GLI1 is directly attributable to these genes acting as downstream targets of SHH/GLI pathway activity, we performed ex vivo inhibition of human BCC explants. This evidence concerns the gene GLI1 and skin basal cell carcinoma.